TARDBP and Alzheimer disease: Finally, with the addition of more cohorts with pathologically confirmed AD and TDP-43 pathology, GWAS can be performed to identify underlying genetic risk factors that may predispose an individual to developing combined tau, Aβ, and TDP-43 pathology.